Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
At their Ignite digital conference on March 2, 2021, Microsoft unveiled a technology meant to enable device- and location-agnostic “shared experiences” via mixed reality applications. Learn more about…
In this review, the authors discuss “actinopathies” in terms of the clinical aspects and cellular mechanisms, with a focus on the effect of these mutations on neutrophil function.…
Michael Banks, MD, announces the launch of the Multiple Myeloma Content Hub on The Doctor’s Channel. Check back soon for interviews with thought leaders in the space, case…
Michael Banks, MD, announces the faculty of The Doctor’s Channel’s upcoming Cases in Thoracic Oncology series. Expert faculty Ross Camidge, MD, PhD, and Erin Schenk, MD, PhD, will…
Raj Chakraborty, MD, assistant professor of medicine at Columbia University Irving Medical Center, discusses promising results from current clinical trials for newly diagnosed multiple myeloma. The GRIFFIN trial…
